Imagilin® Technology, LLC

Imagilin® Technology, LLC, a biotechnology company based in Frederick, Maryland, USA, has been dedicated to developing innovative technologies and nutraceutical products since 2003. The company's emphasis on patented plant-based probiotics has allowed it to rapidly expand in the United States and Asian markets, with a focus on basic research and global clinical studies for all products (founded: 2003). Imagilin®'s commitment to ethical performance and environmental value sets it apart as it collaborates with renowned institutions worldwide to ensure product effectiveness and quality. Notably, the company holds 8 issued patents and several pending patents to support its nutraceutical developments. Its flagship patented probiotic strain, Pediococcus Acidilactici NRRL B-50517, is distributed to companies for use in dietary supplements and food products. Additionally, finished probiotic goods are available to the public through various retail channels and websites (industries: Biotechnology, Health Care). Imagilin® Technology, LLC's disruptive approach to developing cleaner and safer supplements aligns with the market's increasing demand for ethical and effective products. With its innovative probiotic technology platform and strong emphasis on research, the company portrays a promising investment opportunity for venture capitalists.